Biotech Changes Lives
Home
upcoming topic
About
Services
Research
Disclaimer
Contact
✉biotechtoinvest@gmail.com
Biotech Changes Lives
Home
upcoming topic
About
Services
Research
Disclaimer
Contact
✉biotechtoinvest@gmail.com

Research

The best strategy is to know the science behind the investment

Update on possible alternative targets of Anavex2-73
zeus zhangJuly 21, 2022
The Answer Was Here All the Time: Why Anavex2-73 Can Stop Alzheimer’s Disease
zeus zhangJune 15, 2022$AVXL, Anavex, Rett, Alzheimer's, ISRIB, Parkinson's, Sigma-1 receptor
Model portfolio initiated on 1/6/2022
model portfoliozeus zhangJanuary 6, 2022$AVXL, $INMB, $NKTR, $BGNE, Anavex, NEKTAR
Other niche players in AD drug development
Alzheimer's Diseasezeus zhangMarch 23, 2021AVXL, SAVA, CRTX, BIIB, LLY, INMB
All roads lead to Rome: compounds from AVXL and SAVA likely target the same sets of molecules
Alzheimer's Disease, Parkingson's Diseasezeus zhangSeptember 15, 2020Alzheimer's, AVXL, SAVA, CRTX, BIIB, Parkinson, Rett
NKTR-358, an undervalued asset potentially worth more than BEMPEG
immunotherapyzeus zhangJanuary 11, 2020NKTR-358, Eli Lilly, BEMPEG
Update on Cassava Sciences (formerly Pain Therapeutics)
Alzheimer's Diseasezeus zhangDecember 27, 2019SAVA, Cassava, PTI-125

Biotechnologies change lives.
Have a stake in the right ones.

 
logo3.jpg

home | about | services  | research | contact

biotechtoinvest@gmail.com
disclaimer | privacy policy

 

We are a specialized analytics firm with a focus in identifying opportunities for investing in upcoming biotechnology companies.

Powered by Squarespace